YD Bio Ltd. -30YDESWPreferred / convertible
13F holders, Q4 2025 (December 31)12holders +2
2new positions
1sold out
$1.20avg. 13F price*
At the end of Q4 2025, 12 institutions reported holding YD Bio Ltd. -30 (YDESW) in their 13F filings, up 2 from Q3 2025. 2 opened new positions and 1 sold out. The largest holders were Cypress Capital Management LLC (WY) ($4.4M), Oasis Management Co Ltd. ($1.2M) and Cerity Partners LLC ($317K).
- Company
- YD Bio Ltd. -30
- CUSIP
- G9835J103
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2025 → Q4 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 2 | $369 |
| Exits | 1 | $39K |
All 13F filers, Q3 2025 → Q4 2025: 219,934 shares bought and 25,006 shares sold, net +194,928 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 12 holders
| Cypress Capital Management LLC (WY) | — | Add +4.9% | 4,448,658 | $4.4M |
| Oasis Management Co Ltd. | — | No change | 100,000 | $1.2M |
| Cerity Partners LLC | — | Add +2.7% | 320,089 | $317K |
| True North Advisors, LLC | — | Add +0.9% | 221,019 | $219K |
| Clear Street Group Inc. | — | Reduce -6.8% | 94,158 | $93K |
| Merit Financial Group, LLC | — | No change | 40,000 | $40K |
| Concurrent Investment Advisors, LLC | — | No change | 17,672 | $17K |
| T3 Companies, LLC | — | — | 14,849 | $15K |
| Aristeia Capital, L.L.C. | — | No change | 13,274 | $14K |
| Bank of America Corp. | — | Add +32.9% | 404 | $400 |
| UBS Group AG | — | New | 372 | $368 |
| Summit Securities Group LLC | — | New | 1 | $1 |
"% of holder's portfolio" is YDESW's weight in each manager's 13F, not the share of YD Bio Ltd. -30 the manager owns.